Following its mission, GSID has established numerous research collaborations with researchers from both the public and private sectors and academia around the world. We serve as investigational product sponsors by providing AIDSVAX® vaccine to clinical trial sponsors, such as the USMHRP and the NIH. We also collaborate by providing our vaccine, rgp120 reagents, serological specimens and clinical study data to other researcher who are planning the next large-scale HIV vaccine efficacy trials, developing the next generation of HIV vaccines or conduction experiments to better understand why AIDSVAX® B/E was prominent in the partial efficacy demonstrated in RV 144.
If you are interested in collaborating with GSID on our AIDSVAX research, please follow the directions here.
AIDSVAX® Research Collaborations |
No. |
Collaborating Institution |
Investigator(s) |
Type of Collaboration |
1 |
Armed Forces Research Institute for Medical Sciences (AFRIMS)* |
o'Connell, Karasawa, Excler, et.al. |
vaccine, rgp 120 reagents, serological specimens |
2 |
CHUV (Centre Hospitalier Universitaire Vadois)* |
Pantaleo |
clinical study, vaccine |
3 |
Dartmouth College |
Ackerman |
serological specimens |
4 |
Duke University, Department of Medicine, Human Vaccine Institute |
Haynes, Montefiori, Tomares, Moody, et.al. |
rgp 120 reagents, serological specimens, clinical study |
5 |
EuroVacc Foundation* |
Pantaleo |
clinical studies, vaccine |
6 |
Fred C. Hutchinson Cancer Research Center* |
Gilbert, McElrath, Frahm |
clinical study data,rgp 120 reagents |
7 |
GeoVax (private sector company) |
Robinson |
clinical study |
8 |
Harvard University/Beth Israel Deaconess Medical Center* |
Barouch, Shanta |
vaccine |
9 |
HIV Vaccine Trials Network (HVTN)* |
Various |
clinical studies |
10 |
International AIDS Vaccine Initiative (IAVI) |
Priddy |
clinical study |
11 |
Immunetics (private sector company)* |
Levine |
serological specimens |
12 |
iPox Foundation* |
Pantaleo |
clinical studies |
13 |
Joan & Sanford I. Weil Medical College of Cornell University |
Moore |
rgp 120 reagents, serological specimens |
14 |
Los Alamos National Lab |
Korber |
serological specimens |
15 |
Massachusetts General Hospital (Ragon Institute)* |
Alter |
serological specimens |
16 |
Massachusetts Institute of Technology |
Lowe |
serological specimens |
17 |
National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID) / Division of AIDS (DAIDS)* |
Various |
clinical studies, serological specimens |
18 |
NIH / NIAID -Vaccine Research Center* |
Koup, Bailer, Anthos Wyatt, Mascola |
rgp 120 reagents, serological specimens |
19 |
NIH - Biostatistics Research Branch of the Division of Clinical Research |
Follmann |
clinical study data |
20 |
New York University Langone School of Medicine* |
Zolla-Pazner, Marmor, Cardozo |
serological specimens, clinical study data |
21 |
New York University/Veteran's Administration New York Harbor Healthcare System* |
Hioe |
rgp 120 reagents, serological specimens |
22 |
PaxVax (private sector company) |
Gurwith, Connors |
clinical study |
23 |
Rockefeller University/Howard Hughes Medical Institute |
Neuaezweig |
vaccine |
24 |
Rush University Medical Center |
Baum |
rgp 120 reagents |
25 |
San Francisco Department of Public Health |
Buchbinder |
clinical study data |
26 |
Sanofi Pasteur (private sector company)* |
Tartaglia, Phogat, et.al. |
clinical studies |
27 |
SRI International |
Wang |
serological samples |
28 |
Tulane University |
Weazy |
vaccine |
29 |
University of Alabama, Birmingham* |
Shaw, Hahn, Bar |
serological specimens |
30 |
University of California, Irvine* |
Forthal |
rgp 120 reagents |
31 |
University of California, San Francisco* |
Wittington |
clinical study data |
32 |
University of California, Santa Cruz* |
Berman |
rgp 120 reagents, serological specimens |
33 |
University of Kansas |
Desaire |
rgp 120 reagents |
34 |
University of Maryland, Baltimore |
DeVico |
vaccine, serological specimens |
35 |
University of Melbourne |
Kent |
rgp 120 reagents |
36 |
University of Nebraska, Lincoln* |
Li |
vaccine, rgp 120 reagents |
37 |
University of North Carolina, Charlotte |
Sun |
clinical study data |
38 |
University of Pennsylvania* |
Shaw, Hahn, Bar |
serological specimens |
39 |
University of Washington |
Greenberg, Goodreau |
vaccine, clinical study data |
40 |
US Food & Drug Administration |
Krause |
vaccine |
41 |
US Military HIV Research Program (MHRP) and Walter Reed Army Institute of Research (WRAIR)* |
Michael, Kim, Robb, et.al. |
clinical studies, vaccine, rgp 120 reagents, serological specimens |
42 |
Vanderbilt University |
Crowe |
serological specimens |
43 |
University of Rochester |
Johnson |
Clinical study data |
44 |
University of JAEN (Spain) |
Caruz |
Clinical study data |
45 |
University of Rochester |
Johnson |
Clinical study data |
46 |
Ohio State University |
Ganesan |
serological specimens |
47 |
Imperial College, London |
Weber |
Clinical study, vaccine, rgp 120 reagents |
48 |
Mt. Sinai Health System |
Hioe |
rgp reagents |
49 |
University of Georgia |
Song |
VAX004 database subset |
* With these institutions, GSID has entered into multiple cooperative research and development, clinical trial and material transfer agreements.
|
